Recently, U.S. pharmaceutical giant Eli Lilly reached a $2.75 billion trade deal with Hong Kong's Insilico Medicine to bring AI-developed drugs to the world market. This is a powerful step forward in the pharmaceutical industry, paving the way for a future where drugs become more enhanced due to AI. Bringing AI into the medical field allows for reduced research time and quicker molecule synthesis.
AI in the medical industry is definitely very interesting to me. On one hand, it can greatly improve efficiency when it comes to manufacturing and producing drugs, while on the other I question how accurate it can be at actually developing them. If I read that pills were developed from AI systems, I would definitely be skeptical in taking them. I know just how many things can go wrong when using AI, and I know that it can hallucinate often and lead to biased answers. In the end, I think that this deal is a good step in the direction of improving the quality of AI in the medical space as a whole.
Article: https://www.cnbc.com/2026/03/29/eli-lilly-reaches-deal-to-bring-ai-developed-drugs-to-global-market.html
No comments:
Post a Comment